NIGHTTIME SEVERE COLD AND FLU
- Product NDC
- 41226-626
- 11-digit product format
- 412260626
- Labeler code
- 41226
- Product ID
- 41226-626_4716c052-0f4a-2d90-e063-6294a90a9a56
- Type
- HUMAN OTC DRUG
- Nonproprietary name
- ACETAMINOPHEN, DEXTROMETHORPHAN HBR, DOXYLAMINE SUCCINATE, PHENYLEPHRINE HCL
- Dosage form
- CAPSULE, LIQUID FILLED
- Route
- ORAL
- Labeler
- KROGER
- Application
- M012
- Marketing category
- OTC MONOGRAPH DRUG
- Marketing start
- 2020-05-29
- Substance
- DEXTROMETHORPHAN HYDROBROMIDE; ACETAMINOPHEN; DOXYLAMINE SUCCINATE; PHENYLEPHRINE HYDROCHLORIDE
- Active strength
- 10; 325; 6.25; 5 mg/1; mg/1; mg/1; mg/1
- Pharmacologic classes
- Adrenergic alpha1-Agonists [MoA], Antihistamine [EPC], Histamine Receptor Antagonists [MoA], Sigma-1 Agonist [EPC], Sigma-1 Receptor Agonists [MoA], Uncompetitive N-methyl-D-aspartate Receptor Antagonist [EPC], Uncompetitive NMDA Receptor Antagonists [MoA], alpha-1 Adrenergic Agonist [EPC]
- NDC exclude flag
- No
- Listing certified through
- 2026-12-31
- Current FDA listing
- Yes
Observed NDC auxiliary status history#
This history shows the information present in each captured FDA auxiliary file. It is not a continuous regulatory timeline, and a missing record does not establish a status.
| Captured / source date | Dataset | Scope | Package NDC | Code | Status | Snapshot | Source SHA-256 |
|---|---|---|---|---|---|---|---|
| 2025-12-14 17:58 UTC · source 2025-12-05 | excluded product | product | I | Inactivated by FDA | d630ba8d3edf… | 732f749b63fb… | |
| 2025-12-14 17:58 UTC · source 2025-12-05 | excluded package | package | 41226-626-08 | I | Inactivated by FDA | d630ba8d3edf… | 732f749b63fb… |
| 2025-08-27 00:01 UTC · source 2025-08-26 | excluded product | product | I | Inactivated by FDA | f5e01cc5f278… | a2eaf40c39c3… | |
| 2025-08-27 00:01 UTC · source 2025-08-26 | excluded package | package | 41226-626-08 | I | Inactivated by FDA | f5e01cc5f278… | a2eaf40c39c3… |
| 2025-04-01 02:39 UTC · source 2025-03-31 | excluded product | product | I | Inactivated by FDA | 2ef7874e63bc… | 57b86245f4fa… | |
| 2025-04-01 02:39 UTC · source 2025-03-31 | excluded package | package | 41226-626-08 | I | Inactivated by FDA | 2ef7874e63bc… | 57b86245f4fa… |
| 2025-03-28 20:22 UTC · source 2025-03-28 | excluded product | product | I | Inactivated by FDA | a1b67e2a42f9… | c4cf2c586c0d… | |
| 2025-03-28 20:22 UTC · source 2025-03-28 | excluded package | package | 41226-626-08 | I | Inactivated by FDA | a1b67e2a42f9… | c4cf2c586c0d… |
| 2025-03-22 03:12 UTC · source 2025-03-21 | excluded product | product | I | Inactivated by FDA | cfe11265f3b6… | 090c488252e2… | |
| 2025-03-22 03:12 UTC · source 2025-03-21 | excluded package | package | 41226-626-08 | I | Inactivated by FDA | cfe11265f3b6… | 090c488252e2… |
| 2025-03-10 12:48 UTC · source 2025-03-10 | excluded product | product | I | Inactivated by FDA | cdf11ea48f46… | ba0047e9e063… | |
| 2025-03-10 12:48 UTC · source 2025-03-10 | excluded package | package | 41226-626-08 | I | Inactivated by FDA | cdf11ea48f46… | ba0047e9e063… |
| 2025-02-02 03:52 UTC · source 2025-01-31 | excluded product | product | U | Excluded because listing certification expired | 302b2466d912… | e7b80fea0513… | |
| 2025-02-02 03:52 UTC · source 2025-01-31 | excluded package | package | 41226-626-08 | U | Excluded because listing certification expired | 302b2466d912… | e7b80fea0513… |
| 2025-01-20 13:05 UTC · source 2025-01-20 | excluded product | product | U | Excluded because listing certification expired | ed331223b511… | 672a5bd82f5f… | |
| 2025-01-20 13:05 UTC · source 2025-01-20 | excluded package | package | 41226-626-08 | U | Excluded because listing certification expired | ed331223b511… | 672a5bd82f5f… |
| 2025-01-11 03:41 UTC · source 2025-01-10 | excluded product | product | U | Excluded because listing certification expired | 0efc9e666f02… | f202fb6c5f17… | |
| 2025-01-11 03:41 UTC · source 2025-01-10 | excluded package | package | 41226-626-08 | U | Excluded because listing certification expired | 0efc9e666f02… | f202fb6c5f17… |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.
Additional Listing Data#
- Finished product
- Yes
- Brand name base
- NIGHTTIME SEVERE COLD AND FLU
- Listing expiration
- 2026-12-31
Active Ingredients#
| Ingredient | Strength |
|---|---|
| DEXTROMETHORPHAN HYDROBROMIDE | 10 mg/1 |
| ACETAMINOPHEN | 325 mg/1 |
| DOXYLAMINE SUCCINATE | 6.25 mg/1 |
| PHENYLEPHRINE HYDROCHLORIDE | 5 mg/1 |
Harmonized UNII identifiers#
| Identifier | FDA.report destination |
|---|---|
| 9D2RTI9KYH | Internal UNII lookup |
| 362O9ITL9D | Internal UNII lookup |
| V9BI9B5YI2 | Internal UNII lookup |
| 04JA59TNSJ | Internal UNII lookup |
Harmonized SPL set identifiers#
| Identifier | FDA.report destination |
|---|---|
| a690f5c5-ff41-4072-e053-2995a90a8e55 | Available on FDA.report |
DailyMed Product Concepts#
| Product concept | Relation | Version | Effective |
|---|---|---|---|
| e4e263da-1c53-440f-bb80-b7a575843b5a | Product name | 1 | 20260313 |
| d2168cac-a261-415a-9c78-3522859fa720 | Product name | 3 | 20251124 |
| 05a8cdd1-eeb8-409e-b938-0778225eca7d | Product name | 4 | 20250221 |
| e5b5c132-b15d-435b-9faa-2f74e5cadcf9 | Product name | 8 | 20250220 |
| 59361619-24d9-b610-eca6-5a7f25ed5e03 | Product name | 5 | 20240909 |
| f489e8f3-5c9e-4818-b539-a73587edcfc7 | Product name | 2 | 20240229 |
| 0f7ae452-206d-4fc4-868d-56fc47074084 | Product name | 1 | 20231011 |
| b5abe2e3-39a1-43eb-9bff-f3c1653fe3df | Product name | 2 | 20190930 |
| f4368033-af8c-41bf-a84b-ff77392b8522 | Product name | 1 | 20161229 |
| e0b6c8be-f2bd-9f86-a9fc-3ed56ffaa814 | Product name | 3 | 20150910 |
| 4fe95224-f543-4dbb-9445-8cca122b48c8 | Product name | 1 | 20150609 |
| e8718272-64cb-4436-969b-176c3067c8f4 | Product name | 1 | 20150609 |
| 106ff02a-57e1-4c4c-a307-fd582ff4e311 | Product name | 1 | 20150212 |
| 42f3c020-f1b3-89bc-7bdc-e1f10e680485 | Product name | 1 | 20140508 |
| e949165d-714d-e548-2b76-0cb5def16f30 | Product name | 1 | 20140508 |
FDA-Initiated Inactive NDC Indexing#
| NDC | Effective | Action | Document | Indexing SPL | Related label |
|---|---|---|---|---|---|
| 41226-626-08 | 2025-12-29 | C162847 | 48780-1 | 2cef2736-5991-d83d-e063-dadaa90ab31f | KROGER 626T NIGHTTME SEVERE COLD AND FLU |
| 41226-626-08 | 2025-01-30 | C162847 | 48780-1 | 2cef2736-5991-d83d-e063-dadaa90ab31f | KROGER 626T NIGHTTME SEVERE COLD AND FLU |
DailyMed Package Descriptions#
| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|---|---|---|---|---|---|
| 41226-626-08 | NIGHTTIME SEVERE COLD AND FLU | 8 in 1 BLISTER PACK | CAPSULE, LIQUID FILLED | 8 | 4 |
DailyMed Dashboard NDC Coverage#
| NDC | Dashboard title | SPL version | Validation | Dashboard ZIP |
|---|---|---|---|---|
| 41226-626 | NIGHTTIME SEVERE COLD AND FLU (ACETAMINOPHEN, DEXTROMETHORPHAN HBR, DOXYLAMINE SUCCINATE, PHENYLEPHRINE HCL) CAPSULE, LIQUID FILLED [KROGER] | 3 | Current NDC, Legacy NDC, 1 package rows | 20200529_a690f5c5-ff41-4072-e053-2995a90a8e55.zip |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Zicam Extreme Congestion Relief | OXYMETAZOLINE HYDROCHLORIDE | Church & Dwight Co., Inc. | ccada339-656c-a461-e053-2a95a90a3479 | 2025-12-31 | Warnings | M012 |
| ED A-HIST DM | DEXTROMETHORPHAN HYDROBROMIDE, CHLORPHENIRAMINE MALEATE, AND PHENYLEPHRINE HYDROCHLORIDE | EDWARDS PHARMACEUTICALS, INC. | e0e2b117-62bc-4132-9f7c-fe2a912052b1 | 2025-12-31 | Warnings | M012 |
| Bio-Z-Cough | DEXTROMETHORPHAN HYDROBROMIDE, GUAIFENESIN | Advanced Generic Corporation | 05e70eab-1467-4b09-991e-ef03f222e021 | 2025-12-31 | Warnings | M012 |
| Altipres-B | BROMPHENIRAMINE MALEATE, DEXTROMETHORPHAN HYDROBROMIDE, PHENYLEPHRINE HYDROCHLORIDE | Alternative Pharmacal Corporation | fd00c41d-0580-4177-afaa-60bb12ca5a09 | 2025-12-31 | Warnings | M012 |
| Ninjacof-D | CHLOPHEDIANOL HYDROCHLORIDE, PYRILAMINE MALEATE, PSEUDOEPHEDRINE HYDROCHLORIDE | Centurion Labs, LLC | 5188aa20-41f1-4998-81e1-f4de055874bc | 2025-12-31 | Warnings | M012 |
| Llorens Care Tussin DM | DEXTROMETHORPHAN HBR, GUAIFENESIN | Llorens Pharmaceutical International Division, Inc. | 4743e562-1217-50ab-e063-6394a90af88d | 2025-12-31 | Warnings | M012 |
| Llorens Care Tussin | GUAIFENESIN | Llorens Pharmaceutical International Division, Inc. | 474459c1-bfd7-dec7-e063-6394a90ac18d | 2025-12-31 | Warnings | M012 |
| Geri Care Tussin CF Max | ACETAMINOPHEN, DEXTROMETHORPHAN HBR, GUAIFENESIN | GERI-CARE PHARMACEUTICAL CORP | 4744669c-7f33-e35f-e063-6394a90a79b7 | 2025-12-31 | Warnings | M012 |
| Geri-Tussin | GUAIFENESIN | Geri-Care Pharmaceuticals, Corp | 65545ca3-4e93-4b59-9e17-4742e086e8e7 | 2025-12-31 | Warnings | M012 |
| GeriCare Tussin DM Max | DEXTROMETHORPHAN HBR, GUAIFENESIN | GERI-CARE PHARMACEUTICALS, CORP | 47451cd8-7aab-90e2-e063-6394a90ad1b7 | 2025-12-31 | Warnings | M012 |
| Curewell Tussin | GUAIFENESIN | RMT HEALTH LLC | 47455587-5074-e70d-e063-6294a90a78bb | 2025-12-31 | Warnings | M012 |
| Menthol Cough Drops | MENTHOL | Bestco Inc. | 77e25027-3c96-21fa-e053-2991aa0a1f31 | 2025-12-31 | Warnings | M012 |
| Puregen Labs Allergy Relief | DIPHENHYDRAMINE HCL | Advanced Rx LLC | 4745d4f9-bbdf-a4a6-e063-6294a90a15b2 | 2025-12-31 | Warnings | M012 |
| Allergy Relief | DIPHENHYDRAMINE HCL | LLORENS PHARMACEUTICALS INTERNATIONAL DIVISION | 2a46ea9b-29e9-5197-e063-6394a90abc73 | 2025-12-31 | Warnings | M012 |
| Cherry Cough Drops | MENTHOL | Bestco Inc. | 77e50410-306d-b2fb-e053-2a91aa0af3c5 | 2025-12-31 | Warnings | M012 |
| Allergy Relief | DIPHENHYDRAMINE HCL | LLORENS PHARMACEUTICALS INTERNATIONAL DIVISION | e086a6d2-f664-454e-9524-f656bfbf45df | 2025-12-31 | Warnings | M012 |
| Cherry Cough Drops | MENTHOL | Bestco Inc. | 77f45efb-8ee0-1186-e053-2991aa0a9884 | 2025-12-31 | Warnings | M012 |
| Conex Pediatric | DEXBROMPHENIRAMINE MALEATE, PSEUDOEPHEDRINE HCL | Llorens Pharmaceutical International Division | 2a46af43-ef36-e14e-e063-6394a90a8285 | 2025-12-31 | Warnings | M012 |
| Conex | DEXBROMPHENIRAMINE MALEATE, PSEUDOEPHEDRINE HCL | Llorens Pharmaceutical International Division | 2a343656-ac6d-8b20-e063-6294a90ab319 | 2025-12-31 | Warnings | M012 |
| Dologesic NF | ACETAMINOPHEN, DEXBROMPHENIRAMINE MALEATE | Llorens Pharmaceutical International Division | 974fc0d5-7a99-46fb-af38-b91240f728fa | 2025-12-31 | Warnings | M012 |
DailyMed RxNorm Mappings#
| RxCUI | RxNorm string | TTY | DailyMed | SPL version |
|---|---|---|---|---|
| 1297288 | acetaminophen 325 MG / dextromethorphan HBr 10 MG / doxylamine succinate 6.25 MG / phenylephrine HCl 5 MG Oral Capsule | PSN | a2508699-08c0-4a22-e053-2a95a90a8a6d | 3 |
| 1656815 | acetaminophen 325 MG / dextromethorphan HBr 10 MG / guaiFENesin 200 MG / phenylephrine HCl 5 MG Oral Capsule | PSN | a2508699-08c0-4a22-e053-2a95a90a8a6d | 3 |
| 1297288 | acetaminophen 325 MG / dextromethorphan hydrobromide 10 MG / doxylamine succinate 6.25 MG / phenylephrine hydrochloride 5 MG Oral Capsule | SCD | a2508699-08c0-4a22-e053-2a95a90a8a6d | 3 |
| 1656815 | acetaminophen 325 MG / dextromethorphan hydrobromide 10 MG / guaifenesin 200 MG / phenylephrine hydrochloride 5 MG Oral Capsule | SCD | a2508699-08c0-4a22-e053-2a95a90a8a6d | 3 |
| 1297288 | APAP 325 MG / Dextromethorphan Hydrobromide 10 MG / doxylamine succinate 6.25 MG / Phenylephrine Hydrochloride 5 MG Oral Capsule | SY | a2508699-08c0-4a22-e053-2a95a90a8a6d | 3 |
| 1656815 | APAP 325 MG / Dextromethorphan Hydrobromide 10 MG / Guaifenesin 200 MG / Phenylephrine Hydrochloride 5 MG Oral Capsule | SY | a2508699-08c0-4a22-e053-2a95a90a8a6d | 3 |
Packages#
| Package NDC | 11-digit format | Description | Marketing start | Marketing end | Sample | Exclude flag | Status |
|---|---|---|---|---|---|---|---|
| 41226-626-08 | 41226062608 | 8 CAPSULE, LIQUID FILLED in 1 BLISTER PACK (41226-626-08) | 2020-11-16 | 0000-00-00 | No | No | Current |